VAERS Reports AS7164C

VAERS 2605854

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7164C

gering

Staat: MI
Alter: 81,0
Geschlecht: F
Eingang: 29.03.2023
Impfdatum: 25.09.2022
Beginn: 27.01.2023
Tage bis Beginn: 124,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Nasopharyngitis Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

1/27/2023 I thought I had a cold, which I don?t normally get. During the night, my nose was runny. The next day I did an at home COVID test and it was positive. I had a telehealth visit with the nurse. I was prescribed Paxlovid which I started taking that night, 1/28/23. It seemed to help,I got over it really quickly. I took the Paxlovid for 5 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 28JAN23- At Home COVID Test- Positive
Aktuelle Erkrankungen: None
Vorgeschichte: Osteo Arthritis, High Blood Pressure
Andere Medikamente: Quinapril, Potassium Chloride, Furosemide, Amlodipine, Glucosamine Sulphate , Mutli -Vitamin Mineral, Aspirin, Calcium, Extra Strength Tylenol, Fish Oil, Vitamin D3, Turmeric
Allergien: None
Vorherige Impfungen: -

VAERS 2598203

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge As7164c

gering

Staat: CA
Alter: -
Geschlecht: F
Eingang: 17.03.2023
Impfdatum: 23.09.2022
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

Drug ineffective; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 70-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Sep2022 at 12:00 as dose 5 (booster), single (Lot number: As7164c), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Sulfa allergy" (unspecified if ongoing). Concomitant medication(s) included: BUPROPION, stop date: 11Mar2023. The following information was reported: COVID-19 (medically significant) with onset 2023, outcome "unknown"; DRUG INEFFECTIVE (medically significant) with onset 2023, outcome "unknown". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Treatment of Paxlovid started on 12Mar2023.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300109642 Same patient, different drug, different event;

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Sulfonamide allergy
Andere Medikamente: BUPROPION
Allergien: -
Vorherige Impfungen: -